Coronavirus Bioweapon – How China Stole Coronavirus From Canada And Weaponized It

January 26, 2020

Read this report in: हिन्दी

Last year a mysterious shipment was caught smuggling Coronavirus from Canada. It was traced to Chinese agents working at a Canadian lab. Subsequent investigation by GreatGameIndia linked the agents to Chinese Biological Warfare Program from where the virus is suspected to have leaked causing the Wuhan Coronavirus outbreak.

Note: BuzzFeed Reporter Who Attacked GreatGameIndia’s Coronavirus Bioweapon Story, Fired For Plagiarism

The findings of this investigation has been corroborated by none other than the Bioweapons expert Dr. Francis Boyle who drafted the Biological Weapons Convention Act followed by many nations. The report has caused a major international controversy and is suppressed actively by a section of mainstream media.

Infographic based on this report – The Secret History Of Coronavirus

Contents [hide]

• 1 The Saudi SARS Sample
• 2 The Canadian Lab
• 3 Chinese Biological Espionage
• 4 Xiangguo Qiu – The Chinese Bio-Warfare Agent
  • 4.1 Infiltrating the Canadian Lab
• 5 The Wuhan Coronavirus
• 6 Coronavirus Bioweapon
• 7 China’s Biological Warfare Program
  • 7.1 Weaponizing Biotech

Coronavirus Bioweapon – How Chinese agents stole Coronavirus from Canada and weaponized it into a Bioweapon

The Saudi SARS Sample

On June 13, 2012 a 60-year-old Saudi man was admitted to a private hospital in Jeddah, Saudi Arabia, with a 7-day history of fever, cough, expectoration, and shortness of breath. He had no history of cardiopulmonary or renal disease, was receiving no long-term medications, and did not smoke.

Egyptian virologist Dr. Ali Mohamed Zaki isolated and identified a previously unknown coronavirus from his lungs. After routine diagnostics failed to identify the causative agent, Zaki contacted Ron Fouchier, a leading virologist at the Erasmus Medical Center (EMC) in Rotterdam, the Netherlands, for advice. 

Abnormalities on Chest Imaging of the Saudi patient infected with Coronavirus. Shown are chest radiographs of the patient on the day of admission (Panel A) and 2 days later (Panel B) and computed tomography (CT) 4 days after admission (Panel C).

Fouchier sequenced the virus from a sample sent by Zaki. Fouchier used a broad-spectrum “pan-coronavirus” real-time polymerase chain reaction (RT-PCR) method to test for distinguishing features of a number of known coronaviruses known to infect humans.